Key result
Combined preoperative and intraoperative methylprednisolone administration showed no significant difference in reducing post-bypass IL-6 and IL-10 levels compared to preoperative administration alone in children undergoing congenital heart surgery.
Why the study?
Does combined preoperative and intraoperative methylprednisolone reduce post-bypass inflammation compared to preoperative methylprednisolone alone in children under 5 undergoing congenital heart surgery?
RCT (n=50)
Double-blind
Simple random allocation
No
Does combined preoperative and intraoperative methylprednisolone reduce post-bypass inflammation compared to preoperative methylprednisolone alone in children under 5 undergoing congenital heart surgery?
Adding an intraoperative dose of methylprednisolone to a preoperative dose does not further reduce the systemic inflammatory response in children undergoing cardiopulmonary bypass for congenital heart surgery.
Adding intraoperative methylprednisolone shows no IL-6/IL-10 advantage over preoperative dosing alone; leaves open optimal steroid strategy in pediatric CPB.
BACKGROUND: Steroid administration during cardiopulmonary bypass is considered to improve cardiopulmonary function by modulating inflammations caused by bypass. OBJECTIVES: This study was performed to compare effectiveness of preoperative and intraoperative methylprednisolone (MP) to preoperative methylprednisolone alone in post bypass inflammatory (IL-6) and anti-inflammatory (IL-10) factors. PATIENTS AND METHODS: Fifty pediatric patients undergoing cardiopulmonary bypass surgery from August 2011 to 2012 in the cardiac surgery department of Imam Reza Hospital, the major center for CPB, in Mashhad, Iran were randomly assigned to receive preoperative and intraoperative MP (30 mg/kg, 4 hours before bypass and in bypass prime, number 25) or preoperative MP only (30 mg/kg, number 25). Before and after bypass, four and 24 hours after bypass, serum IL-6 and IL-10 were measured by ELISA. RESULTS: In both groups, no significant difference with variation of expression for IL-6 (inflammatory factor) and IL-10 (anti-inflammatory factor) in different times after bypass was observed. CONCLUSIONS: No significant difference in reducing post bypass inflammation between preoperative steroid treatment and combined preoperative and intraoperative steroid administration reported and they had the same effects.
No takes yet. Share an insight, caveat, or question.
Tashnizi et al. (2013) conducted an RCT in Congenital heart disease requiring cardiopulmonary bypass (n=50). Combined preoperative and intraoperative methylprednisolone vs. Preoperative methylprednisolone only (30 mg/kg 4 hours before bypass) was evaluated on Changes in serum levels of IL-6 and IL-10 before and after cardiopulmonary bypass (p=NS). Combined preoperative and intraoperative methylprednisolone administration showed no significant difference in reducing post-bypass IL-6 and IL-10 levels compared to preoperative administration alone in children undergoing congenital heart surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: